URSO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 669
AS - Asia 612
EU - Europa 473
SA - Sud America 84
AF - Africa 8
OC - Oceania 5
Totale 1.851
Nazione #
US - Stati Uniti d'America 649
SG - Singapore 427
IT - Italia 231
BR - Brasile 74
DE - Germania 72
CN - Cina 53
ID - Indonesia 48
FI - Finlandia 36
GB - Regno Unito 32
NL - Olanda 28
AT - Austria 24
CA - Canada 19
IN - India 14
VN - Vietnam 12
BE - Belgio 11
HK - Hong Kong 11
LT - Lituania 10
IR - Iran 9
SE - Svezia 8
TH - Thailandia 8
CZ - Repubblica Ceca 6
KR - Corea 6
AU - Australia 4
AR - Argentina 3
CO - Colombia 3
EG - Egitto 3
IQ - Iraq 3
JP - Giappone 3
RU - Federazione Russa 3
TR - Turchia 3
IL - Israele 2
IS - Islanda 2
MY - Malesia 2
PK - Pakistan 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
UA - Ucraina 2
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 1.851
Città #
Santa Clara 215
Singapore 182
Chandler 60
Jakarta 45
Shanghai 36
New York 30
Milan 29
Ashburn 28
Ferrara 24
Helsinki 23
Bologna 19
Fairfield 18
London 17
Nuremberg 17
Frankfurt am Main 16
Los Angeles 15
Munich 14
Lappeenranta 13
Dong Ket 12
Falkenstein 11
Hong Kong 11
Houston 10
Ottawa 10
Vienna 10
Boardman 9
Brussels 9
Rome 9
Toronto 9
Buriram 8
Parma 8
Wilmington 7
Cambridge 6
Ferrara di Monte Baldo 6
Princeton 6
Bremen 5
Brno 5
Poggio Renatico 5
San Diego 5
Woodbridge 5
Brasília 4
Lizzano in Belvedere 4
Monza 4
Rovigo 4
Seattle 4
Sydney 4
Addison 3
Ann Arbor 3
Belo Horizonte 3
Cagliari 3
Cairo 3
Chicago 3
Como 3
Copparo 3
Florence 3
Hounslow 3
Isfahan 3
Istanbul 3
Kochi 3
Alpharetta 2
Bandung 2
Chandigarh 2
Cipolletti 2
Dej 2
Doha 2
Easley 2
Forlì 2
Incheon 2
Kanazawa 2
Knoxville 2
Kuala Lumpur 2
Lisbon 2
Maglie 2
Manaus 2
Medellín 2
Molfetta 2
North Bergen 2
Occhiobello 2
Padova 2
Pelotas 2
Perugia 2
Reggio Emilia 2
Reykjavik 2
Sala Baganza 2
Sandston 2
Santa Cruz 2
São Paulo 2
Turnhout 2
Uberaba 2
Acarigua 1
Agrate Conturbia 1
Alzano Lombardo 1
Amsterdam 1
Anápolis 1
Aparecida de Goiânia 1
Atlanta 1
Auckland 1
Bacabal 1
Baghdad 1
Bandar Seri Begawan 1
Barbosa 1
Totale 1.102
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 111
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 86
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 73
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 67
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 58
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 56
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 54
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 52
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 52
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 51
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 51
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 49
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 48
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 44
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 39
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 39
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 38
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 36
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 36
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 36
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 36
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 35
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 33
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 33
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 30
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 30
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 30
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 28
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 28
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 27
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 27
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 27
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 26
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 26
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 25
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 25
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 24
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 23
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 23
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 22
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 22
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 21
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 20
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 20
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 20
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 19
Is There a Role for FAPI PET in Urological Cancers? 19
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 18
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 18
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 18
Molecular imaging of PARP in cancer: state-of-the-art 18
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 17
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 17
18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients 16
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 16
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 16
Clinical applications of long axial field-of-view PET/CT scanners in oncology 16
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 14
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 12
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 12
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 10
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 10
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 10
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 9
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 9
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 8
Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives 6
Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? 2
Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 2
Triple Tracer PET in Advanced Prostate Cancer: Chasing Phenotypic Plasticity 2
Molecular Imaging in Cancer Chemoresistance: What’s Brewing? 1
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 1
Totale 2.053
Categoria #
all - tutte 18.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 1 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/20251.372 74 87 190 104 235 144 87 110 341 0 0 0
Totale 2.053